Spinal Noradrenergic Modulation and the Role of the Alpha-2 Receptor in the Antinociceptive Effect of Intrathecal Nefopam in the Formalin Test
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Nefopam has shown an analgesic effect on acute pain including postoperative pain. The reuptake of monoamines including serotonin and noradrenaline has been proposed as the mechanism of the analgesic action of nefopam, but it remains unclear. Although alpha-adrenergic agents are being widely used in the perioperative period, the role of noradrenergic modulation in the analgesic effect of nefopam has not been fully addressed. Methods: Changes in the antinociceptive effect of intrathecal (i.t.) nefopam against formalin-elicited flinching responses were explored in Sprague-Dawley rats pretreated with i.t. 6-hydroxydopamine (6-OHDA), which depletes spinal noradrenaline. In addition, antagonism to the effect of nefopam by prazosin and yohimbine was evaluated to further elucidate the antinociceptive mechanism of i.t. nefopam. Results: Pretreatment with i.t. 6-OHDA alone did not alter the flinching responses in either phase of the formalin test, while it attenuated the antinociceptive effect of i.t. nefopam significantly during phase 1, but not phase 2. The antagonist of the alpha-2 receptor, but not the alpha-1 receptor, reduced partially, but significantly, the antinociceptive effect of i.t. nefopam during phase 1, but not during phase 2. Conclusions: This study demonstrates that spinal noradrenergic modulation plays an important role in the antinociceptive effect of i.t. nefopam against formalin-elicited acute initial pain, but not facilitated pain, and this action involves the spinal alpha-2 but not the alpha-1 receptor.
Abstract
Background: Nefopam has shown an analgesic effect on acute pain including postoperative pain. The reuptake of monoamines including serotonin and noradrenaline has been proposed as the mechanism of the analgesic action of nefopam, but it remains unclear. Although alpha-adrenergic agents are being widely used in the perioperative period, the role of noradrenergic modulation in the analgesic effect of nefopam has not been fully addressed. Methods: Changes in the antinociceptive effect of intrathecal (i.t.) nefopam against formalin-elicited flinching responses were explored in Sprague-Dawley rats pretreated with i.t. 6-hydroxydopamine (6-OHDA), which depletes spinal noradrenaline. In addition, antagonism to the effect of nefopam by prazosin and yohimbine was evaluated to further elucidate the antinociceptive mechanism of i.t. nefopam. Results: Pretreatment with i.t. 6-OHDA alone did not alter the flinching responses in either phase of the formalin test, while it attenuated the antinociceptive effect of i.t. nefopam significantly during phase 1, but not phase 2. The antagonist of the alpha-2 receptor, but not the alpha-1 receptor, reduced partially, but significantly, the antinociceptive effect of i.t. nefopam during phase 1, but not during phase 2. Conclusions: This study demonstrates that spinal noradrenergic modulation plays an important role in the antinociceptive effect of i.t. nefopam against formalin-elicited acute initial pain, but not facilitated pain, and this action involves the spinal alpha-2 but not the alpha-1 receptor.
참고문헌 (36)
- Fuller RW, "Evaluation of nefopam as a monoamine uptake inhibitor in vivo in mice", Neuropharmacology, 32, pp.995~999 (1993)
- Rosland JH, "The effect of nefopam and its enantiomers on the uptake of 5-hydroxytryptamine, noradrenaline and dopamine in crude rat brain synaptosomal preparations", J Pharm Pharmacol, 42, pp.437~438 (1990)
- Vonvoigtlander PF, "Involvement of biogenic amines with the mechanisms of novel analgesics", Prog Neuropsychopharmacol Biol Psychiatry, 7, pp.651~656 (1983)
- Esposito E, "Evidence of the involvement of dopamine in the analgesic effect of nefopam", Eur J Pharmacol, 128, pp.157~164 (1986)
- Hunskaar S, "Involvement of central serotonergic pathways in nefopam-induced antinociception", Eur J Pharmacol, 138, pp.77~82 (1987)
- Girard P, "Role of catecholamines and serotonin receptor subtypes in nefopam-induced antinociception", Pharmacol Res, 54, pp.195~202 (2006)
- Millan MJ, "Descending control of pain", Prog Neurobiol, 66, pp.355~474 (2002)
- Benarroch EE, "Descending monoaminergic pain modulation:bidirectional control and clinical relevance", Neurology, 71, pp.217~221 (2008)
- 조수영, "Antinociceptive Effect of Intrathecal Nefopam and Interaction with Morphine in Formalin-Induced Pain of Rats", The Korean Journal of Pain, 26(1), pp.14~20 (2013), 대한통증학회
- Bernatzky G, "Intrathecal injection of codeine, buprenorphine, tilidine, tramadol and nefopam depresses the tail-flick response in rats", Eur J Pharmacol, 120, pp.75~80 (1986)
- Fasmer OB, "Antinociceptive effects of (+", -)-, (+)- and (-)-nefopam in mice, 1987, pp.39, 508~511
- Girard P, "Nefopam potentiates morphine antinociception in allodynia and hyperalgesia in the rat", Pharmacol Biochem Behav, 77, pp.695~703 (2004)
- Tramoni G, "Morphinesparing effect of nefopam by continuous intravenous injection after abdominal surgery by laparotomy", Eur J Anaesthesiol, 20, pp.990~992 (2003)
- Kranke P, "Single-dose parenteral pharmacological interventions for the prevention of postoperative shivering: a quantitative systematic review of randomized controlled trials", Anesth Analg, 99, pp.718~727 (2004)
- Lu KZ, "Ondansetron does not attenuate the analgesic efficacy of nefopam", Int J Med Sci, 201(10), pp.1790~1794
- Höcker J, "Nefopam but not physostigmine affects the thermoregulatory response in mice via alpha(2)-adrenoceptors", Neuropharmacology, 58, pp.495~500 (2010)
- Coderre TJ, "The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury", J Neurosci, 12, pp.3665~3670 (1992)
- Suzuki T, "The antiallodynic and antihyperalgesic effects of neurotropin in mice with spinal nerve ligation", Anesth Analg, 101, pp.793~799 (2005)
- Uutela P, "Analysis of intact glucuronides and sulfates of serotonin, dopamine, and their phase I metabolites in rat brain microdialysates by liquid chromatography-tandem mass spectrometry", Anal Chem, 81, pp.8417~8425 (2009)
- Shin DJ, "Receptors involved in the antinociception of intrathecal melatonin in formalin test of rats", Neurosci Lett, 494, pp.207~210 (2011)
- Gutierrez T, "Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociception", Brain Res, 987, pp.176~185 (2003)
- Shin DJ, "Receptors involved in the antinociception of intrathecal melatonin in formalin test of rats", Neurosci Lett, 494, pp.207~210 (2011)
- Marazziti D, "Analgesia by nefopam: does it act through serotonin?", Drugs Exp Clin Res, 17, pp.259~261 (1991)
- Ohkubo Y, "Involvement of dopamine in the mechanism of action of FR64822, a novel non-opioid antinociceptive compound", Eur J Pharmacol, 204, pp.121~125 (1991)
- Verleye M, "Nefopam blocks voltage-sensitive sodium channels and modulates glutamatergic transmission in rodents", Brain Res, 1013, pp.249~255 (2004)
- Novelli A, "Nefopam inhibits calcium influx, cGMP formation, and NMDA receptor-dependent neurotoxicity following activation of voltage sensitive calcium channels", Amino Acids, 28, pp.183~191 (2005)
- Verleye M, "Contribution of transient receptor potential vanilloid subtype 1 to the analgesic and antihyperalgesic activity of nefopam in rodents", Pharmacology, 83, pp.116~121 (2009)
- Nakajima K, "An increase in spinal cord noradrenaline is a major contributor to the antihyperalgesic effect of antidepressants after peripheral nerve injury in the rat", Pain, 153, pp.990~997 (2012)
- Romero TR, "CB1 and CB2 cannabinoid receptor agonists induce peripheral antinociception by activation of the endogenous noradrenergic system", Anesth Analg, 116, pp.463~472 (2013)
- Wada T, "Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity", Eur J Pharmacol, 340, pp.45~52 (1997)
- Yaksh TL, "Wall and Melzack's textbook of pain", pp.371~414 (2006), Elsevier
- Day HE, "Distribution of alpha 1a-, alpha 1b- and alpha 1d-adrenergic receptor mRNA in the rat brain and spinal cord", J Chem Neuroanat, 13, pp.115~139 (1997)
- Gil DW, "Alpha-1-adrenergic receptor agonist activity of clinical alpha-adrenergic receptor agonists interferes with alpha-2-mediated analgesia", Anesthesiology, 110, pp.401~407 (2009)
- Van Elstraete AC, "Median effective dose (ED50) of paracetamol and nefopam for postoperative pain: isobolographic analysis of their antinociceptive interaction", Minerva Anestesiol, 79, pp.232~239 (2013)
- Girard P, "Nefopam and ketoprofen synergy in rodent models of antinociception", Eur J Pharmacol, 584, pp.263~271 (2008)
- Delage N, "Median effective dose (ED50) of nefopam and ketoprofen in postoperative patients: a study of interaction using sequential analysis and isobolographic analysis", Anesthesiology, 102, pp.1211~1216 (2005)